Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
Background: Treatment for severe malaria must be prompt with effective parenteral antimalarial drugs for at least 24 h to achieve fast parasite clearance, and when the patient can tolerate oral therapy, treatment should be completed with effective artemisinin based combination therapy (ACT) for comp...
Main Authors: | Byakika-Kibwika, P, Ssenyonga, R, Lamorde, M, Blessborn, D, Tarning, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMC
2019
|
Similar Items
-
Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults.
by: Byakika-Kibwika, P, et al.
Published: (2012) -
Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
by: Creek, D, et al.
Published: (2013) -
Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
by: Zongo, I, et al.
Published: (2014) -
Treatment failure of dihydroartemisinin/piperaquine for plasmodium falciparum malaria, Vietnam
by: Phuc, B, et al.
Published: (2017) -
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
by: Valecha, N, et al.
Published: (2010)